Diagnosis and clinical manifestations of bacterial vaginosis.

PubWeight™: 3.66‹?› | Rank: Top 1%

🔗 View Article (PMID 3259075)

Published in Am J Obstet Gynecol on April 01, 1988

Authors

D A Eschenbach1, S Hillier, C Critchlow, C Stevens, T DeRouen, K K Holmes

Author Affiliations

1: Department of Obstetrics and Gynecology, University of Washington, Seattle 98195.

Associated clinical trials:

Safety and Efficacy Study of Lactobacillus Administered Vaginally in Women With Bacterial Vaginosis | NCT00635622

Safety Study of Lactobacillus Administered Vaginally to Healthy Women | NCT00537576

Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis (TBVAP) | NCT01471457

Articles citing this

Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol (1989) 3.06

Gram-positive anaerobic cocci. Clin Microbiol Rev (1998) 2.34

Bacterial vaginosis. Clin Microbiol Rev (1991) 2.27

The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2.24

Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis. J Clin Microbiol (1990) 2.22

Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol (1994) 1.89

Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health (2001) 1.86

Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? Sex Transm Infect (2000) 1.74

Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol (2000) 1.74

Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin Microbiol Rev (1992) 1.67

Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group. Genitourin Med (1997) 1.66

Social and sexual risk factors for bacterial vaginosis. Sex Transm Infect (2004) 1.54

Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol (2010) 1.43

Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use. Antimicrob Agents Chemother (2008) 1.43

Targeting Trojan Horse leukocytes for HIV prevention. AIDS (2010) 1.40

Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol (1992) 1.38

Is bacterial vaginosis a sexually transmitted infection? Sex Transm Infect (2001) 1.36

Comparative study of vaginal Lactobacillus phages isolated from women in the United States and Turkey: prevalence, morphology, host range, and DNA homology. Clin Diagn Lab Immunol (2001) 1.28

Reservoir of four organisms associated with bacterial vaginosis suggests lack of sexual transmission. J Clin Microbiol (1990) 1.22

The aetiology of bacterial vaginosis. J Appl Microbiol (2011) 1.22

Understanding vaginal microbiome complexity from an ecological perspective. Transl Res (2012) 1.19

A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17

Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians. Sex Transm Infect (2010) 1.16

Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol (1996) 1.12

Life in the littoral zone: lactobacilli losing the plot. Sex Transm Infect (2005) 1.10

BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol (2003) 1.07

Prevalence of bacterial vaginosis and correlation of clinical to Gram stain diagnostic criteria in low risk pregnant women. Eur J Epidemiol (1999) 1.07

Reproducibility of a scoring system for gram stain diagnosis of bacterial vaginosis. J Clin Microbiol (1991) 1.06

The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol (1999) 1.04

Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol (2006) 1.04

Evaluation of the enhanced rapid identification method for Gardnerella vaginalis. J Clin Microbiol (1989) 1.02

Analysis of vaginal acetic acid in patients undergoing treatment for bacterial vaginosis. J Clin Microbiol (2004) 1.01

Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect Dis Obstet Gynecol (2004) 1.01

Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis. J Biol Chem (2013) 0.99

Bacterial vaginosis: an overview for 2009. Rev Obstet Gynecol (2009) 0.99

Bacterial vaginosis: a diagnostic approach. Genitourin Med (1992) 0.98

Association between bacterial vaginosis and cervical intraepithelial neoplasia. J Gynecol Oncol (2009) 0.97

Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis (2009) 0.94

Asymptomatic non-ulcerative genital tract infections in a rural Ugandan population. Sex Transm Infect (1998) 0.93

Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections. Sex Transm Infect (2004) 0.93

Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection. Infect Dis Obstet Gynecol (2005) 0.92

Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol (2014) 0.92

Microbiological, epidemiological and clinical correlates of vaginal colonisation by Mobiluncus species. Genitourin Med (1991) 0.91

Six years observation after successful treatment of bacterial vaginosis. Infect Dis Obstet Gynecol (1997) 0.91

Vaginal microflora associated with bacterial vaginosis in nonpregnant women: reliability of sialidase detection. Infect Dis Obstet Gynecol (2001) 0.91

Bacterial vaginosis: prevalence in outpatients, association with some micro-organisms and laboratory indices. Genitourin Med (1989) 0.90

Involvement of Gardnerella vaginalis in urinary tract infections in men. J Clin Microbiol (1992) 0.90

The laboratory diagnosis of bacterial vaginosis. Can J Infect Dis Med Microbiol (2005) 0.89

S1-Guideline on Bacterial Vaginosis in Gynecology and Obstetrics: Long version - AWMF Guideline, registration no. 015/028, July 2013 Langfassung - AWMF-Register Nr. 015/028, Juli 2013. Geburtshilfe Frauenheilkd (2014) 0.89

Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol (2000) 0.89

Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device. Infect Dis Obstet Gynecol (2003) 0.88

DNA hybridization test: rapid diagnostic tool for excluding bacterial vaginosis in pregnant women with symptoms suggestive of infection. J Clin Microbiol (2002) 0.88

Experience with routine vaginal pH testing in a family practice setting. Infect Dis Obstet Gynecol (2004) 0.87

First trimester bacterial vaginosis, individual microorganism levels, and risk of second trimester pregnancy loss among urban women. Fertil Steril (2007) 0.87

Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis. Infect Dis Obstet Gynecol (2009) 0.85

High levels of Gardnerella vaginalis detected with an oligonucleotide probe combined with elevated pH as a diagnostic indicator of bacterial vaginosis. J Clin Microbiol (1992) 0.85

Evaluation of two clinical protocols for the management of women with vaginal discharge in southern Thailand. Sex Transm Infect (1998) 0.85

Accuracy and trust of self-testing for bacterial vaginosis. J Adolesc Health (2012) 0.84

Sexually transmitted diseases in children: non viral including bacterial vaginosis, Gardnerella vaginalis, mycoplasmas, Trichomonas vaginalis, Candida albicans, scabies and pubic lice. Genitourin Med (1994) 0.83

Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract. J Infect Dis (2013) 0.83

Prevalence of bacterial vaginosis among pregnant women attending antenatal care in Tikur Anbessa University Hospital, Addis Ababa, Ethiopia. BMC Res Notes (2014) 0.83

Vaginal lactobacilli as potential probiotics against Candida SPP. Braz J Microbiol (2010) 0.82

Accuracy of Self-Report of Sexual Activity among Adolescent Girls: Implications for Interpretation of Vaginal Flora Patterns. MBio (2015) 0.82

Tinidazole vs metronidazole for the treatment of bacterial vaginosis. Am J Obstet Gynecol (2010) 0.82

Vaginal symptoms and bacterial vaginosis (BV): how useful is self-report? Development of a screening tool for predicting BV status. Epidemiol Infect (2007) 0.82

Evaluation and management of vaginitis. J Gen Intern Med (1998) 0.81

Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis. PLoS One (2013) 0.81

Gynecologic Complications of Bacterial Vaginosis: Fact or Fiction? Curr Infect Dis Rep (1999) 0.80

Comparison of Gram stain and Pap smear procedures in the diagnosis of bacterial vaginosis. Infect Dis Obstet Gynecol (2002) 0.80

Bacterial vaginosis and season, a proxy for vitamin D status. Sex Transm Dis (2014) 0.80

Methods employed by genitourinary medicine clinics in the United Kingdom to diagnose bacterial vaginosis. Sex Transm Infect (2005) 0.80

Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort study. Infect Dis Obstet Gynecol (2012) 0.79

Treatment of acute pelvic inflammatory disease. Infect Dis Obstet Gynecol (2011) 0.79

Assessing the prevalence of bacterial vaginosis among infertile women of Qom city. Iran J Microbiol (2014) 0.79

Evaluation of specific symptoms of bacterial vaginosis among pregnant women. Infect Dis Obstet Gynecol (1997) 0.79

Abnormal vaginal pH and Mycoplasma genitalium infection. J Pediatr Adolesc Gynecol (2012) 0.78

Damage to oviduct organ cultures by Gardnerella vaginalis. Int J Exp Pathol (2011) 0.78

Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch Gynecol Obstet (2015) 0.78

Evaluation of a fast test to identify the presence of proline aminopeptidase in women with bacterial vaginosis. Infect Dis Obstet Gynecol (1997) 0.78

The antimicrobial effects of selenium nanoparticle-enriched probiotics and their fermented broth against Candida albicans. Daru (2014) 0.76

Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses. J Infect Dis (2016) 0.76

Correlation between the clinical diagnosis of bacterial vaginosis and the results of a proline aminopeptidase assay. Infect Dis Obstet Gynecol (1994) 0.75

Comparative analysis of syndromic and PCR-based diagnostic assay reveals misdiagnosis/ overtreatment for trichomoniasis based on subjective judgment in symptomatic patients. Infect Dis Poverty (2016) 0.75

Bacterial vaginosis and trichomoniasis: epidemiology and management of recurrent disease. Infect Dis Obstet Gynecol (1995) 0.75

Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases. Clin Infect Dis (2015) 0.75

The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease. Arch Gynecol Obstet (1991) 0.75

Articles by these authors

Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63

Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91

Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61

Diagnosis of coliform infection in acutely dysuric women. N Engl J Med (1982) 8.75

Characterization of plasmid deoxyribonucleic acid from Neisseria gonorrhoeae. Infect Immun (1974) 8.30

Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements. J Infect Dis (1975) 7.92

Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med (1983) 7.89

The serological classification of Neisseria gonorrhoeae. I. Isolation of the outer membrane complex responsible for serotypic specificity. J Exp Med (1976) 7.85

Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med (1978) 7.07

Causes of the acute urethral syndrome in women. N Engl J Med (1980) 6.91

Anaerobic bacteria in nonspecific vaginitis. N Engl J Med (1980) 6.74

Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis (1985) 6.32

Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96

Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med (1974) 5.68

Disseminated gonococcal infection. Ann Intern Med (1971) 5.66

Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun (1982) 5.54

Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest (1976) 5.54

Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis (1984) 5.40

Clinical spectrum of pharyngeal gonococcal infection. N Engl J Med (1973) 5.34

A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med (1988) 5.32

Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99

Quantitative determination of antibody to gonococcal pili. Changes in antibody levels with gonococcal infection. J Clin Invest (1973) 4.90

Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74

AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68

Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA (1986) 4.62

Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol (1983) 4.42

Studies of venereal disease. I. Probenecid-procaine penicillin G combination and tetracycline hydrochloride in the treatment of "penicillin-resistant" gonorrhea in men. JAMA (1967) 4.38

Selective differential human blood bilayer media for isolation of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 4.28

Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23

Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23

Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol (1989) 4.03

Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol (1986) 3.67

A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med (1982) 3.66

Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother (1985) 3.66

Isolation of viruses, bacteria and other organisms from venereal disease clinic patients: methodology and problems associated with multiple isolations. Health Lab Sci (1973) 3.62

Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA (1988) 3.58

Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56

Low antibiotic resistance of gonococci causing disseminated infection. N Engl J Med (1973) 3.48

An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol (1970) 3.46

Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.44

Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med (1987) 3.42

Studies of venereal disease. 3. Double-blind comparison of tetracycline hydrochloride and placebo in treatment of nongonococcal urethritis. JAMA (1967) 3.40

The Chlamydia epidemic. JAMA (1981) 3.35

Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med (1980) 3.33

Epidemiology of genital human papillomavirus infection. Epidemiol Rev (1988) 3.32

Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med (1981) 3.32

National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25

Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23

Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22

Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18

Chlamydia trachomatis as a cause of acute "idiopathic" epididymitis. N Engl J Med (1978) 3.16

Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect (2006) 3.16

The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12

DNA hybridization technique for the detection of Neisseria gonorrhoeae in men with urethritis. J Infect Dis (1983) 3.11

Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03

Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02

Clinical manifestations of vaginal trichomoniasis. JAMA (1989) 2.97

Evidence for the retraining of sensation after stroke: a systematic review. Clin Rehabil (2009) 2.96

Identification of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 2.96

Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med (1984) 2.89

Studies of venereal disease. II. Observations on the incidence, etiology, and treatment of the postgonococcal urethritis syndrome. JAMA (1967) 2.84

Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect (1998) 2.83

Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis (1996) 2.76

Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76

Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74

A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med (1984) 2.71

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol (2001) 2.69

Sexual bridging by Cambodian men: potential importance for general population spread of STD and HIV epidemics. Sex Transm Dis (2000) 2.66

Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65

Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis (1985) 2.64

Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J Rheumatol (1992) 2.58

Single oral dose ampicillin-probenecid treatment of gnorrhea in the male. JAMA (1971) 2.56

Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55

Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun (1982) 2.55

Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health (1999) 2.54

Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase. Nature (1991) 2.48

Antenatal microbiologic and maternal risk factors associated with prematurity. Am J Obstet Gynecol (1990) 2.44

Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med (1984) 2.44

Spectinomycin versus tetracycline for the treatment of gonorrhea. N Engl J Med (1977) 2.44

Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis (1989) 2.41

Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41

Asymptomatic gonorrhea in men: caused by gonococci with unique nutritional requirements. Science (1977) 2.37

Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping. N Engl J Med (1982) 2.36

Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med (1983) 2.33

Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, Washington. J Clin Microbiol (1987) 2.33

Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol (1977) 2.31

Spectinomycin and penicillin G in the treatment of gonorrhea. A comparative evaluation. JAMA (1972) 2.30

Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex Transm Dis (1987) 2.27

Circumcision and sexually transmitted diseases. Am J Public Health (1994) 2.27

Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis. J Clin Invest (1979) 2.25

Single doses of methacycline and doxycycline for gonorrhea: a cooperative study of the frequency and cause of treatment failure. J Infect Dis (1973) 2.23

Gonococcal infections. Ann Intern Med (1985) 2.23